Inovio Pharmaceuticals Inc INO gained 1.6% to $7.59. Inovio Pharmaceuticals publishes successful Phase 2b trial results of its HPV immunotherapy in The Lancet. Share volume totaled 773,000, compared to an all-day average of 1.4 million
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
